請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58754
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 吳瑞碧 | |
dc.contributor.author | Wen-Chang Chang | en |
dc.contributor.author | 張文昌 | zh_TW |
dc.date.accessioned | 2021-06-16T08:29:13Z | - |
dc.date.available | 2019-01-27 | |
dc.date.copyright | 2014-01-27 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-01-09 | |
dc.identifier.citation | 參考文獻
行政院衛生署全民健康保險局。挑戰 2025 糖尿病醫療國際論壇。全民健康保險。2011, 92, 15。 林秀娟。2003。高血脂防治手冊:國人血脂異常診療及預防指引。行政院衛生署國民健康局。 林育嬋,謝秋蘭,彭耀寰。2006。芭樂心葉水萃取物對抑制葡萄糖及雙羰化合物誘導糖尿病血管併發症相關因子之功效評估。弘光科技大學生物科技研究所碩士論文。 姜佩均,吳懿哲。2010。糖化蛋白對內皮前驅細胞功能異常之影響及丹參在治療上可能扮演之角色。國立陽明大學傳統醫藥研究所碩士論文。 張鑑熹,李弘膜。2000。過度糖化最終產物在RAW 264.7 細胞誘導iNOS表現中蛋白質激酶 C 所扮演的角色。台北醫學大學生物醫學研究所碩士論文。 陳欣妤,黃文鑫。2006。合成具晚期糖化終產物阻斷劑及抗發炎潛能之噻唑衍生物。國防醫學院藥學研究所碩士論文。 陳健民,李弘膜。2000。cAMP依賴性的蛋白激酶對過度糖化最終產物誘導 RAW264.7 吞噬細胞 iNOS 表現和 NO 產生的調控。台北醫學大學生物醫學研究所碩士論文。 Ahmed, N. and Thornalley, P. J. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 2007, 9, 233–245. Ahmed, N.; Thornalley, P. J.; Luthen, R.; Haussinger, D.; Sebekova, K.; Schinzel, R.; Voelker, W.; Heidland, A. Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis. J. Hepatol. 2004, 41, 913-919. American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care. 2008, 31, S55-S60. Ankrah, N. A. and Appiah-Opong, R. Toxicity of low levels of methylglyoxal: depletion of blood glutathione and adverse effect on glucose tolerance in mice. Toxicol. Lett. 1999, 109, 61-67. Anwar, J.; Spanevello, R. M.; Thome, G.; Stefanello, N.; Schmatz, R.; Gutierres, J.; Schetinger, M. R. Effects of caffeic acid on behavioral parameters and on the activity of acetylcholinesterase in different tissues from adult rats. [Research Support, Non-U.S. Gov't]. Pharmacol. Biochem. Behav. 2012, 103, 386-394. Arivarasu, N. A.; Priyamvada, S.; Mahmood, R. Caffeic Acid Inhibits Chromium(VI)-Induced Oxidative Stress and Changes in Brush Border Membrane Enzymes in Rat Intestine. Biol. Trace Elem. Res. 2012, 148, 209-215. Arrbias-Lorenzo, G. and Morales, F. J. Analysis, distribution, and dietary exposure of glyoxal and methylglyoxal in cookies and their relationship with other heat-induced contaminants. J. Agric. Food Chem. 2010, 58, 2966−2972. Auzanneau, C.; Montaudon, D.; Jacquet, R.; Puyo, S.; Pouysegu, L.; Deffieux, D.; Elkaoukabi-Chaibi, A.; De Giorgi, F.; Ichas, F.; Quideau, S.; Pourquier, P. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the alpha isoform of human DNA topoisomerase II. Mol. Pharmacol. 2012, (doi: 10.1124/mol.111.077537). Barros, A.; Rodrigues, J. A.; Almeida, P. J.; Oliva-Teles, M. T. Determination of glyoxal, methylglyoxal and diacetyl in selected beer and wine by HPLC with UV spectrophotometric detection after derivatization with o-phenylendiamine. J. Liq. Chromatogr. Relat. Technol. 1999, 22, 2061−2069. Becker, H.; Scher, J. M.; Speakman, J. B.; Zapp, J. Bioactivity guided isolation of antimicrobial compounds from Lythrum salicaria. Fitoterapia. 2005, 76, 580-584. Beckman, J.; Creager, M.; Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. J.A.M.A. 2002, 287, 2570-2581. Biemel, K. M.;Friedl, D. A.;Lederer, M. O. Identification and quantification of major maillard cross-links in human serum albumin and lens protein. J. Biol. Chem. 2002, 277, 24907–24915. Boutten, A.; Goven, D.; Artaud-Macari, E.; Boczkowski, J.; Bonay, M. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease.Trends Mol. Med. 2011, 17, 363-371. Brambilla, G.; Sciabà, L.; Faggin, P.; Maura, A.; Marinari, U. M.; Ferro, M.; Esterbauer, H. Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutat. Res. 1986, 171, 169-176. Brands, A. M. A.; Kessels, R. P. C.; de Haan, E. H. F.; Kappelle, L. J.; Biessels, G. J. Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels. Eur. J. Pharmacol. 2004, 490, 159-168. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced glycation end products in tissue and the biochemical basis of diabetic complication. N. Engl. J. Med. 1988a, 318, 1315-1321. Brownlee, M.; Cerami, A.; Vlassara, H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab. Rev. 1988b, 4, 437–451. Bucala, R.; Makita, Z.; Kozchinsky, T.; Cerami, A.; Vlassara, H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6434-6438. Buetler, T. M.; Leclerc, E.; Baumeyer, A.; Latado, H.; Newell, J.; Adolfsson, O.; Parisod,V.; Richoz, J.; Maurer, S.; Foata, F.; Piguet, D.; Junod, S.; Heizmann, C. W.; Delatour, T. N-Carboxymethyllysine-medified proteins are unable to bind to RAGE and activate an inflammatory response. Molecular Nutrition & Food Chemistry 2008, 52, 370–378. CDCP. Diabetes surveillance: atlanta department of health and human services. 1997. Chang, L. and Karin, M. Mammalian MAP kinase signaling cascades. Nature 2001, 410, 37-40. Chang, T.; Wang, R.; Wu, L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic. Biol. Med. 2005, 38, 286-293. Chang, W. C. and Shen, S. C. Effect of water extracts from edible Myrtaceae plants on uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) in tumor necrosis factor-α-treated FL83B mouse hepatocytes. Phytother. Res. 2013, 27, 236-243. Chang, W. C.; Shen, S. C. and Wu, J. S. B. Protective effects of vescalagin from pink wax apple [Syzygium samarangense (Blume) Merrill and Perry] fruit against methylglyoxal-induced inflammation and carbohydrate metabolic disorder in rats. J. Agric. Food Chem. 2013, 61, 7102-7109. Chao, J.; Li, H. J.; Yao, Y. Y.; Shen, B.; Gao, L.; Bledsoe, G.; Chao, L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 2007, 49, 490-497. Charonis, A. S.; Reger, L. A.; Dege, J. E.; Kouzii-Koliakos, K.; Furcht, L. T. Lamimin alterations after in vivo nonenzymatic glycosylation. Diabetes 1990, 39, 807-814. Chartoumpekis, D. V.; Ziors, P. G.; Psyrogiannis, A. I.; Papavassiliou, A. G.; Kyriazopoulou, V. E.; Sykiotis, G. P.; Habeos, I. G. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice. Diabetes 2011, 60, 2465–2473. De Revel, G.; Bertrand, A. A method for the detection of carbonyl compounds in wine: glyoxal and methylglyoxal. J. Sci. Food Agric. 1993, 61, 267−272. DeFronzo, R. A.; Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14, 173-194. Department of Health, Exeutive Yuan, Taiwan, R.O.C. 2010。http://www.doh.gov.tw. Desai, K. and Wu, L. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons? Recent Pat. Cardiovasc. Drug Discov. 2007, 2, 89-99. Dhar, A.; Desai, K. M.; Wu, L. Alagebrium attenuates acute methylglyoxal-induced glucose intolerance in Sprague-Dawley rats. B. J. P. 2010, 159, 166–175. Dhar, A.; Dhar, I.; Jiang, B.; Desai, K. M.; Wu, L. Chronic methylglyoxal infusion by minipump causes pancreatic β-cell dysfunction and induces type 2 diabetes in sprague-dawley rats. Diabetes 2011, 60, 899–908. Di Loreto, S.; Caracciolo, V.; Colafarina, S.; Sebastiani, P.; Gasbarri, A.; Amicarelli, F. Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1 beta and nerve growth factor in cultured hippocampal neuronal cells. Brain Res. 2004, 1006, 157-167. Doble, B. W. and Woodgett, J. R. Role of Glycogen Synthase Kinase-3 in Cell Fate and Epithelial-Mesenchymal Transitions. Cells Tissues Organs 2007, 185, 73-84. Dong, C.; Davis, R. J.; Flavell, R. A. MAP kinase in the immune response. Annu. Rev. Immunol. 2002, 20, 66-72. Dong, Q.; Yang, K.; Wong, S. M.; O’Brien, P. J. Hepatocyte or serum albumin protein carbonylation by oxidized fructose metabolites: Glyceraldehyde or glycolaldehyde as endogenous toxins? Chem. Biol. Interact. 2010, 188, 31-37. Duh, P. D.; Lin, S. L. and Wu, S. C. Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl4-induced liver damage and inflammation. J. Ethnopharmacol. 2011, 134, 379–385. Faist, V. and Erbersdobler, H. F. Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann. Nutr. Metab. 2001, 45, 1-12. Fleming, T. H.; Humpert, P. M.; Nawroth, P. P.; Bierhaus, A. Reactive metabolites and AGE/RAGE mediated cellular dysfunction affect the aging process – A mini-review. Gerontology 2011, 57, 435–443. Forster, A.; Kuhne, Y. and Henle, T. Studies on absorption and elimination of dietary maillard reaction products. Ann. N. Y. Acad. Sci. 2005, 1043, 474-481. Fridrich, D.; Glabasnia, A.; Fritz, J.; Esselen, M.; Pahlke, G.; Hofmann, T.; Marko, D. Oak ellagitannins suppress the phosphorylation of the epidermal growth factor receptor in human colon carcinoma cells. J. Agric. Food Chem. 2008, 56, 3010-3015. Fukunaga, M.; Miyata, S.; Higo, S.; Hamada, Y.; Ueyama, S.; Kasuga, M. Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells. Ann. N. Y. Acad. Sci. 2005, 1043, 151-157. Grandhee, S. K. and Monnier, V. M. Mechanism of formation of the Mailard protein cross-link petosodine. J. Biol. Chem. 1991, 266, 11649-11653. Guo, Q.; Mori, T.; Jiang, Y.; Hu, C.; Osaki, Y.; Yoneki, Y.; Sun, Y.; Hosoya, T.; Kawamata, A.; Ogawa, S..; Nakayama, M.; Miyata, T.; Ito, S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J. Hypertens. 2009, 27, 1664-1671. Haan, M. N. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat. Clin. Pract. Neuro. 2006, 2, 159-166. Heber, D. Multitargeted therapy of cancer by ellagitannins. Cancer lett. 2008, 269, 262-268. Herve Du Penhoat, C. L. M.; Michon, V. M. F. L.; Ohassan, A.; Peng, S.; Scalberg, A; Gage, D. Roburin A, a dimeric ellagitannin from heartwood of quercus robur. Phytochemistry 1991, 30, 329–332. Hicks, M.; Delbridge, L.; Yue, D.; Reeve, R. Catalysis of lipid peroxidation by glucose and glycosylated proteins. Biochem. Biophys. Res. Commun. 1988, 151, 649-655. Hirosumi, J.; Tuncman, G.; Chang, L.; Görgün, C. Z.; Uysal, K. T.; Maeda, K. Karin, M.; Hotamisligil, G. S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420, 333-336. Hotamisligil, G. S. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27, Suppl. 2003, 3, S53–S55. International Diabetes Federation. Global diabetes plan 2011-2021. 2011, 1-28. Jack, M.; Ryals, J. and Wright, D. Protection from diabetes-induced peripheral sensory neuropathy-α role for elevated glyoxalase I ? Exp. Neurol. 2012, 234, 62–69. Jaiswal, A. K. Antioxidant response element. Biochem. Pharmacol. 1994, 48, 439-444. Janbaz, K. H.; Saeed, S. A.; Gilani, A. H. Protective effect of rutin on paracetamol and CCl4-induced hepatotoxicity in rodents. Fitoterapia 2002, 73, 557–563. Jean-Gilles, D.; Li, L.; Ma, H.; Yuan, T.; Chichester, C. O.; Seeram, N. P. Anti-inflammatory effects of polyphenolic-enriched red raspberry extract in an antigen-induced arthritis rat model. J. Agric. Food Chem. 2011, (on line). Kalapos, M. P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 1999, 110, 145-175. Kameswara Roa, B.; Sudarshan Renuka, P.; Rajasekhar, M. D.; Nagaraju, N.; Appa Roa, C. Antidiabetic activity of Terminalia pallida fruit in alloxan induced diabetic rats. J. Ethnopharmacol. 2003, 85, 169-172. Kang, J. H. Oxidative damage of DNA by the reaction of amino acid with methylglyoxal in the presence of Fe (III). Int. J. Biol. Macromol. 2003, 33, 43-48. Koschinsky, T.; He, C. J.; Mitsuhashi, T.; Bucala, R.; Liu, C.; Buenting, C.; Heitmann, K.; Vlassara, H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Nati. Acad. Sci. U. S. A. 1997, 94, 6474-6479. Koyu, A.; Gokalp,O.; Gumral, N.; Oktem, F.; Karahan, N.;Yilmaz, N.;Saygin, M. Impact of caffeic acid phenethyl ester treatment on vancomycin-induced pancreatic damage in rats. Toxicol. Ind. Health 2013, 1–7. Kurrer, M. O.; Pakala, S. V.; Hanson, H. L.; Katz, J. D. Beta cell apoptosis in T cell-media ted autoimmune diabetes. PNAS 1997, 94, 213–218. Ledesma, M. D.; Bonay, P.; Colaço, C.; Avila, J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J. Biol. Chem. 1994, 269, 21614-21619. Lee, B. H.; Hsu, W. H.; Chang, Y. Y.; Kuo, H. F.; Hsu, Y. W.; Pan, T. M. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radic. Biol. Med. 2012, 53, 2008-2016. Lee, B. H.; Hsu, W. H.; Hsu, Y. W.; Pan, T. M. Dimerumic acid protects pancreas damage and elevates insulin production in methylglyoxal-treated pancreatic RINm5F cells. J. Funct. Foods 2013, 5, 642-650. Lester-Coll, N.; Rivera, E. J.; Soscia, S. J.; Doiron, K.; Wands, J. R.; de la Monte, S. M. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 2006, 9, 13-33. Li, Y. M.; Dickson, D.W. Enhanced binding of advanced glycation end products (AGE) by the ApoE4 isoform links the mechanism of plague deposition in Alzheimer’s disease. Neurosci. lett. 1997, 226, 155-158. Lin, R. S.; Lee, W. C. Trends in mortality from diabetes mellitus in Taiwan. 1960-1988. Diabetologia. 1992, 35, 973-979. Luo, Y.; Eggler, A. L.; Liu, D.; Liu, G.; Mesecar, A. D.; Van Breemen, R. B. Sites of alkylation of human Keap1 by natural chemoprevention agents. J. Am. Soc. Mass Spectrome. 2007, 18, 2226-2232. Lyons, T. J.;Bailie, K. E.;Dyer, D. G.;Dunn, J. A.;Baynes, J. W. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J. Clin. Invest. 1991, 87, 1910-1915. Makida, Z.; Radoff, S.; Rayfield, E. J.; Yang, Z.; Skolnir, E. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 1991, 325,836-842. Matafome, P.; Sena, C. and Seiça, R. Methylglyoxal, obesity, and diabetes. Endocrine. 2013, 43, 472-484. McDougall, G. J. and Stewart, D. The inhibitory effects of berry polyphenols on digestive enzymes. BioFactors 2005, 23, 189–195. McLellan, A. C.; Thornalley, P. J.; Benn, J.; Sonksen, P. H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin. Sci. (Lond.) 1994, 87, 21-29. McMahon, M.; Thomas, N.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a 'tethering' mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 2006, 281, 24756-24768. Mnafgui, K.; Kchaou, M.; Hamden, K.; Derbali, F.; Slama, S.; Nasri, M.; Salah, H. B.; Allouche, N; Elfeki, A. Inhibition of carbohydrate and lipid digestive enzymes activities by Zygophyllum album extracts: effect on blood and pancreas inflammatory biomarkers in alloxan-induced diabetic rats. J. Physiol. Biochem. 2013.(online) More, S. S.; Vartak, A. P. and Vince, R. Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease. ACS Chem. Neurosci. 2013, 4, 330-338. Morrish, N. J.; Wang, S. L.; Stevens, L. K.; Fuller, J. H.; Keen, H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 2001, 44, S14-S21. Munch, G., Mayr, S., Michaelis, J., Hipkiss, A.R., Reiderer, P., Muller, R., Neumman, A., Schinzel, R., and Cunningham, A.M. Infuence of advanced glycation end products and AGE-inhibitors on nucleation-dependent polymerization of beta amyloid peptide. Biochem. Biophys. Acta. 1997, 1360, 17-29. Myhrstad, M. C.; Husberg, C.; Murphy, P.; Nordstrom, O.; Blomhoff, R.; Moskaug, J. O.; Kolsto, A. B. TCF11/Nrf1 overexpression increases the intracellular glutathione level and can transactivate the gamma-glutamylcysteine synthetase (GCS) heavy subunit promoter. Biochim. Biophys. Acta. 2001, 1517, 212-219. Nain, P.; Saini, V.; Sharma, S.; Nain, J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J. Ethnopharmacol. 2012, 142, 65-71. Nakayama, H.; Mitsuhashi, T.; Kuwajima, S.; Aoki, S.; Kuroda, Y.; Itoh, T.; Nakagawa, S., Immunohistochemical localization of advanced glycation end products in lens crystalline from streptozocin-induced diabetic rats. Diabetes 1993, 42, 345-350. Negre-Salvayre, A.; Salvayre, R.; Auge, N.; Pamplona, R.; Portero-Otin, M. Hyperglycemia and glycation in diabetic complications. Antioxid. Redox Signal. 2009, 11, 3071-3109. Nemet, I.; Varga-Defterdarovic, L. and Turk, Z. Methylglyoxal in food and living organisms. Mol. Nutr.Food Res. 2006, 50, 1105-1117. Novotny, G. W.; Lundh, Morten.; Backe, M. B.; Christensen, D. P.; Hansen, J. B.; Dahllof, M. S.; Pallesen, E. M. H.; Mandrup-Poulsen, T. Transcriptional and translational regulation of cytokine signaling in inflammatory β-cell dysfunction and apoptosis. Arch. Biochem. Biophys. 2012, 528, 171-184. Oboh, G.; Agunloye, O.; Akinyemi, A.; Ademiluyi, A.; Adefegha, S. Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-In Vitro. Neurochem. Res. 2013, 38, 413-419. Panchal, S. K. and Brown, L. Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats. Eur. J. Nutr. 2012, (on line). Parola, M.; Leonarduzzi, G.; Biasi, F.; Albano, E.; Biocca, M. E.; Poli, G.; Dianzani, M. U. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology. 1992, 16, 1014-1021. Peppa, M.;Uribarri, J.;Vlassara, H. Glucose, advanced glycation endproducts, and diabetes complications:what is new and what works. Clin. Diabetes. 2003, 21, 186-187. Pi, J.; Zhang, Q.; Fu, J.; Woods, C. G.; Hou, Y.; Corkey, B. E.; Collins, S.; Andersen, M. E. ROS signaling oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol. Appl. Pharm. 2010, 244, 77–83. Pongor, S.; Ulrich, P. C. and Bencsath, F.A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. 1984, 81, 2684-2688. Price, C. L. and Knight, S. C. Methylglyoxal: possible link between hyperglycaemia and immune suppression? Trends Endocrinol. Metab. 2009, 20, 312-317. Quideau, S.; Douat-Casassus, C.; Delannoy López, D. M.; Di Primo, C.; Chassaing, S.; Jacquet, R.; Saltel, F.; Genot, E. Binding of filamentous actin and winding into fibrillar aggregates by the polyphenolic C-glucosidic ellagitannin vescalagin. Angew. Chem. Int. Ed. Engl. 2011, 50, 5099-5104. Quideau, S.; Jourdes, M.; Saucier, C.; Glories, Y.; Pardon, P.; Baudry C. DNA topoisomerase inhibitor Acutissimin A and other flavano-ellagitannins in red wine. Angew. Chem. Int. Ed. Engl. 2003, 115, 6194 –6196 Rabbani, N. and Thornalley P. J. Methylglyoxal, glyoxalase 1 and dicarbonyl proteome. Amino acids 2012, 42, 1133-1142. Ramasamy, R.; Yan, S. and Schmidt, A. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann. N. Y. Acad. Sci. 2011, 1243, 88-102. Ramasamy, R.; Yan, S. F.; Schmidt, A. M. Methylglyoxal comes of AGE. Cell 2006, 124, 258-260. Reaven, G. M. Role of insulin resistance in human disease. Diabetes 1988, 37, 1595-1607. Resurreccion-Magno, M.; Villasenor, I.; Harada, N. and Monde, K. Antihyperglycaemic flavonoids from Syzygium samarangense (Blume) Merr. and Perry. Phytother. Res. 2005, 19, 246-251. Riboulet-Chavey, A.; Pierron, A.; Durand, I.; Murdaca, J.; Giudicelli, J.; Van Obberghen, E. Methylglyoxal impairs the insulin signaling pathways independently of the formation of intracellular reactive oxygen species. Diabetes 2006, 55, 1289-1299. Ridker, P. M.; Cushman, M.; Stampfer, M. J.; Tracy, R. P.; Hennekens, C. H. Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997, 336, 973-979. Ristow, M. Neurodegenerative disorders associated with diabetes mellitus. J. Mol. Med. (berl) 2004, 82, 510-529. Satish Kumar, M.; Mrudula, T.; Mitra, N.; Bhanuprakash Reddy, G. Enhanced degradation and decreased stability of eye lens alpha-crystallin upon methylglyoxal modification. Exp. Eye Res. 2004, 79, 577-583. Shahidi, S.; Komaki, A.; Mahmoodi, M.; Atrvash, N.; Ghodrati, M. Ascorbic acid supplementation could affect passive avoidance learning and memory in rat. Brain Res. Bull. 2008, 76, 109-113. Sharabi, Y.; Oron-Herman, M. and Kamari, Y. Effect of PPAR-γ agonist on adiponectin levels in metabolic syndrome: lessons from the high fructose fed rats model. Am. J. Hypertens. 2007, 20, 206–210. Shen, S. C. and Chang, W. W. Hypotriglyceridemic and hypoglycemic effects of vescalagin from Pink wax apple [Syzygium samarangense (Blume) Merrill and Perry cv. Pink] in high-fructose diet-induced diabetic rats. Food Chem. 2013, 136, 858–863. Simirgiotis, M.; Adachi, S.; To, S.; Yang, H.; Reynertson, K.; Basile, M.; Gil, R.; Weinstein, I.; Kennelly, E. Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu). Food Chem. 2008, 107, 813-819. Singh, I.; Singh, P. K.; Bhansali, S.; Shafiq, N.; Malhotra, S.; Pandhi, P.; Singh, A. P. Effects of three different doses of a fruit extract of Terminalia chebula on metabolic components of metabolic syndrome, in a rat model. Phytother. Res. 2010, 24, 107-112. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: a review. Diabetologia 2001, 44, 129–146. Smith, M. A.; Siedlak, S. L.; Richey, P. L.; Nagaraj, R. H.; Elhammer, A.; Perry, G. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer’s disease. Brain Res. 1996, 717, 99-108. Suarez, G.; Rajaram, R.; Oronsky, A. L. and Gawinowicz, M. A. Nonenzymatic glycation of bovine serum albumin by fructose (fructation). comparison with the Maillard reaction initiated by glucose. J. Biol. Chem. 1989, 264, 3674-3679. Sugimoto, K.; Hosotani, T.; Kawasaki, T.; Nakagawa, K.; Hayashi, S.; Nakano, Y.; Inui, H.; Yamanouchi, T. Eucalyptus leaf extract suppresses the postprandial elevation of portal, cardiac and peripheral fructose concentrations after sucrose ingestion in rats. J. Clin. Biochem. Nutr. 2010, 46, 205-211. Sureshkumar, S.V. and Mishra, S. H. Hepatoprotective effect of extracts from Pergularia daemia Forsk. J. Ethnopharmacol. 2006, 107, 164–168. Surh, Y. J.; Kundu, J. K. and Na, H. K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008, 74, 1526-1539. Susic, D. and Varagic, J. Crosslink breakers: a new approach to cardiovascular therapy. Curr. Opin. Cardiol. 2004, 19, 336-340 Takeuchi, M. and Yamagishi, S. Alternative routes for the formation of glyceraldehyde derived AGEs (TAGE) in vivo. Medical Hypotheses 2004a, 63, 453-455. Takeuchi, M. and Yamagishi, S. TAGE (toxic AGEs) hypothesis in various chronic diseases. Medical Hypotheses 2004b, 63, 449-452. Takeuchi, M.; Takino, J. and Yamagishi, S. Involvement of TAGE-RAGE system in the pathogenesis of diabetic retinopathy. J. Ophthalmol. 2010, doi: 10.1155/2010/170393. Talalay, P.; Dinkova-Kostova, A. T. and Holtzclaw, W. D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 2003, 43, 121-134. Tan, H. P.; Wong, D. Z.; Ling, S. K.; Chuah, C. H.; Kadir, H. A. Neuroprotective activity of galloylated cyanogenic glucosides and hydrolysable tannins isolated from leaves of Phyllagathis rotundifolia. Fitoterapia, 2012, 83, 223-229. Taylor, S. I. and Arioglu, E. Syndromes associated with insulin resistance and acanthosis nigricans. J. Basic Clin. Physiol. Pharmacol. 1998, 9, 419-439. Thornalley, P. J. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 2003, 31, 1343–1348. Thornalley, P. J.; Langborg, A. and Minhas, H. S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 1999, 344, 109-116. Thorpe, S. R. and Baynes, J. W. Role of the maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 1996, 9, 69-77. Tsai, C. C. and Chen, H. J. C. Chemistry of the maillard reaction and its inhibition in vivo. Chemistry 2002, 60, 335-349. Tsuda, S.; Egawa, T.; Ma, X.; Oshima, R.; Kurogi, E.; Hayashi, T. Coffee polyphenol caffeic acid but not chlorogenic acid increases 5′AMP-activated protein kinase and insulin-independent glucose transport in rat skeletal muscle. J. Nutr. Biochem. 2012, 23, 1403-1409. Uribarri, J.; Woodruff, S.; Goodman, S.; Cai, W.; Chen, X.; Pyzik, R.; Yong, A.; Striker, G. E.; Vlassara, H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet Assoc. 2010, 110, 911-916. Vander Jagt, D. L. and Hunsaker, L. A. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem. Biol. Interact. 2003, 143, 341–351. Verzijl, N.;Degroot, J.;Oldehinkel, E.;Bank, R. A.;Thorpe, S. R.;Baynes, J. W.;Bayliss, M. T. Age-related accumulation of maillard reaction products in human articular cartilage collagen. Biochem. J. 2000, 350, 381-387. Vilhelmova, N.; Jacquet, R.; Quideau, S.; Stoyanova, A.; Galabov, A. S. Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2. Antiviral Res. 2011, 89, 174-181. Vlassara, H, and Palace, M. R. Diabetes and advanced glycation endproducts. J. Intern. Med. 2002, 251, 87-101. Wang, J. and Chang, T. Methylglyoxal content in drinking coffee as a cytotoxic factor. J. Food Sci. 2010, 75, H167−H171. Wang, X.; Gu, C.; He, W.; Ye, X.; Chen, H.; Zhang, X.; Hai, C. Glucose oxidase induces insulin resistance via influencing multiple targets in vitro and in vivo: The central role of oxidative stress. Biochimie. 2012, 94, 1705-1717. Wang, X.; Ye, X. L.; Liu, R.; Chen, H. L.; Bai, H.; Liang, X.; Zhang, X. D.; Wang, Z.; Li, W. L.; Hai, C. X. Antioxidant activities of oleanolic acid in vitro: possible role of Nrf2 and MAP kinases. Chem. Biol. Interact. 2010, 184, 328-337. Weston, R. C. and Davis, R. J. The JNK signal transduction pathway. Curr. Opin. Cell. Biol. 2007, 19, 142-149. Whiting, D. R.; Guariguata, L.; Weil, C.; Shaw, J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94, 311-321. WHO. 2013. http://www.who.int/diabetes/en/index.html Yamada, T.; Kuno, A.; Masuda, K.; Ogawa, K.; Sogawa, M.; Nakamura, S.; Ando, T.; Sano, H.; Nakazawa, T.; Ohara, H.; Nomura, T.; Joh, T.; Itoh, M. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J. Pharmacol. Exp. Ther. 2003, 307, 17-23. Yamagishi, S. I.; Amano, S.; Inagaki, Y.; Okamoto, T.; Koga, K..; Sasaki, N.; Makita, Z. Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys. Res. Commun. 2002, 290, 973-978. Yamagishi, S.; Takeuchi, M.; Inagaki, Y.; Nakamura, K.; Imaizumi, T. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int. j. clin. pharmacol. res. 2003, 23, 129-134. Yan, S. D.; Schmidt, A. M.; Anderson, G. M.; Zhang, J.; Brett, J.; Zou, Y. S.; Pinsky, D.; Stern, D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 1994, 269, 9889-9897. Yang, L. L.; Lee, C. Y. and Yen, K. Y. Induction of apoptosis by hydrolysable tannins from Eugenia jambos L. on human leukemia cells. Cancer Lett. 2000, 157, 65-75. Yildiz, G.; Demiryürek, A. T.; Sahin-Erdemli, I.; Kanzik, I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br. J. Pharmacol. 1998, 124, 905-910. Yu, X. and Kensler, T. Nrf2 as a target for cancer chemoprevention. Mutat. Res. 2005, 591, 93-102. Yu, Z. W.; Li, D.; Ling, W. H.; Jin, T. R. Role of nuclear factor (erythroid-derived 2)-like 2 in metabolic homeostasis and insulin action: A novel opportunity for diabetes treatment? W. J. D. 2012, 3, 19–28. Zhang, W. W.; McCall, L. I.; Matlashewski, G. Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani. Eukaryot. Cell 2013, 12, 70-77. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58754 | - |
dc.description.abstract | 隨著人們生活水平與醫療技術的提升,慢性疾病已逐漸成為人民主要的健康威脅。根據世界衛生組織 (world health organization) 2011 年統計數據顯示,全球糖尿病罹患人數高達 3.46 億人,也推測此疾病之擴展速度二十年內應該會有雙倍之成長,故此慢性疾病預防顯得格外重要。現今社會中已有多數民眾罹患肥胖、代謝症候群及糖尿病之現況,而其主要原因則為飲食中含高量之果糖所致。已有文獻指出,甲基乙二醛 (methylglyoxal, MG) 為一種高活性的雙羰基化合物,是糖類物質代謝後之產物之一,亦為糖化終產物 (advanced glycation end products, AGEs) 主要之前驅物質,且 MG 與 AGEs 更與肥胖、代謝症候群及糖尿病之病因有極密切的關係。另外有研究指出,當 MG 與 AGEs 存在會促進體內活性氧 (reactive oxygen species)、氧化壓力 (oxidative stress) 及發炎細胞激素 (inflammatory cytokine) 之增生,導致胰臟細胞受攻擊而損傷。因此,減少體內 MG 之含量可有效抑制 AGEs 的形成進而預防糖尿病之發生。
Vescalagin (VES) 屬於鞣酸 (ellagitannin) 類化合物,是水解性單寧,屬植物多酚類物質,具抗菌、抗氧化、抗發炎及抗癌之功效。先前本實驗室研究發現 VES 具有減緩肝臟細胞胰島素阻抗之功效,且於高果糖誘發之糖尿病大鼠亦發現其具調解血糖、胰島素、減少血清中三酸甘油脂形成與降低游離脂肪酸之能力。但因目前 VES 此化合物尚未有人大量生產販售,故根據先前之研究方法從粉紅種蓮霧生果中進行萃取及純化,同時因未有利用 VES 預防 MG 誘導大鼠醣類代謝異常之相關實驗報告,故本研究先評估 VES 是否可有效預防 MG 所誘發之大鼠體內發炎與糖類代謝異常,再進一步了解 VES 是否藉由改善胰臟細胞中之抗氧化酵素活性與胰島素分泌之相關蛋白表現來預防血糖異常。 結果顯示,VES 可有效降低口服葡萄糖耐受性 (oral glucose tolerance)、動脈硬化風險指標 (cardiovascular risk index)、血脂(serum lipid)、果糖胺 (fructosamine)、糖化終產物 (AGEs)、腫瘤壞死因子 (tumor necrosis factor-α) 與介白素-6 (Interleukin 6) 之含量;同時可有效提升血液中之胰島素、C-peptide 與 D-乳酸含量,根據上述結果發現,VES 可預防 MG 所誘發之大鼠血糖代謝異常。結果亦顯示,VES 可降低胰臟細胞中糖化終產物受器 (RAGE)、細胞核因子kappa B (NF-κB) 與磷酸化 mitogen-activated protein kinases (MAPKs) 蛋白之表現,同時 VES 也促進胰島素合成蛋白正調控pancreatic-duodenal homeobox-1 (PDX-1) 蛋白表現及抑制負調控蛋白CCAAT/enhancer binding proteins-β(C/EBPβ) 之表現。另外,VES 可藉由促進抗氧化轉錄因子nuclear factor-erythroid 2-related factor 2 (Nrf2) 之蛋白表現及麩胱甘肽 (glutathione) 含量之增加來提升胰臟細胞中之抗氧化能力。故推論 VES 是藉由提升胰臟細胞中之抗氧化酵素活性來保護胰臟細胞免於遭受甲基乙二醛攻擊而降低 MG 誘發大鼠高血糖之現象。綜合上述之實驗結果,VES 應具潛力開發為食品補充劑以預防糖尿病之發生。 | zh_TW |
dc.description.abstract | As advanced medical technology and improved living standard extended the expectancy of human life, chronic diseases have become a major threat to the health of people. Diabetes mellitus (DM) is a chronic disease involving inflammation in the development. The World Health Organization estimated that more than 346 million people worldwide suffered from DM in 2011. This number is likely to become more than double by 2030 in case of no intervention. The prevalence of DM, obesity, and many other metabolic syndromes has been linked to the increased consumption of fructose-containing foods. MG is a highly reactive dicarbonyl metabolite produced during glucose metabolism, and it is a major precursor of advanced glycation end products (AGEs) that are involved in the pathogenesis of inflammation, metabolic syndromes and diabetes. MG and AGEs also promote the production of reactive oxygen species and inflammatory cytokines that cause the damage of pancreatic β-cells. Therefore, to reduce the MG content can be effective in the retard of AGEs formation and the prevention of DM.
Ellagitannins are bioactive polyphenols with antioxidant and anti-inflammatory activities. Pink wax apple fruit contain the ellagitannin vescalagin (VES). VES has been reported to be antibacterial, antitumor, insulin-resistance alleviative and dyslipidemia mediative. Our laboratory previously reported that VES may reduce serum glucose content with a simultaneous increase in the serum insulin and C-peptide levels. No commercial VES is available on the market. Therefore, we extracted and purified VES from young pink wax apple. No literatures with regard to the protective effect of VES on pancreatic β-cells against MG induced inflammation and hyperglycemia has been reported yet. The aims of this study were to investigate the preventive effect of VES against MG-induced inflammation and carbohydrate metabolic disorder in rats and to elucidate its mechanism by assessing on the activities of oxidation enzymes and the expressions of insulin secretion-related protein in pancreatic β-cells in rats orally administered with MG and VES. Results showed that VES reduced the value of oral glucose tolerance test, serum lipid, cardiovascular risk index, fructosamine, AGEs, tumor necrosis factor-α and Interleukin 6 (IL-6) contents while increased insulin, C-peptide and D-lactate contents significantly in the rats orally administered with MG and VES together. Further, we want to elucidate the mechanism by assessing the effect of VES on inflammation and insulin secretion of pancreatic β-cells in MG-induced diabetic rats. The results revealed that VES down-regulated the expressions of advanced glycation end products receptor (RAGE), the nuclear factor kappa B (NF-κB) and the phosphorylation of mitogen-activated protein kinases (MAPKs) in the β-cells, and that VES promoted insulin synthesis via the up-regulation of pancreatic-duodenal homeobox-1 (PDX-1) and the down-regulation of MG-mediated CCAAT/enhancer binding proteins-β(C/EBPβ) expression. VES was also found to promote the translocation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and glutathione (GSH) to increase antioxidant enzymes activity in MG-induced diabetic rats. We propose that the mechanism for VES to protect pancreatic β-cells of rats against methylglyoxal-induced inflammation and hyperglycemia involves the promotion of antioxidative ability in these cells. These findings suggest the potential for VES to become an ingredient of food supplement in the prevention of diabetes and its complications. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:29:13Z (GMT). No. of bitstreams: 1 ntu-103-D99641001-1.pdf: 5624735 bytes, checksum: 2cf347e4bf0004789a972184851d192c (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 謝 誌 I
中 文 摘 要 II Abstract IV 縮寫表 VI 目 錄 IX 圖 次 XV 表 次 XVIII 第一章 前言 1 第二章 文獻回顧 3 第一節 糖尿病 3 一、糖尿病流行病學 3 二、糖尿病及其併發症 7 三、糖尿病分類 9 第二節 甲基乙二醛誘發動物模式之建構 13 一、甲基乙二醛簡介 13 二、MG 的生成與代謝 14 三、MG 對蛋白質與核酸之作用 18 四、MG 對細胞之作用 20 五、MG 控制之重要性 22 第三節 過度糖化終產物 (Advanced Glycation End Products, AGEs) 23 一、AGEs 的形成 23 二、AGEs 的結構分類 26 三、AGEs 的致病機制 28 四、AGEs 累積及其併發症 29 第四節 Nuclear factor erythroid 2-related factor 2 (Nrf2) 32 第五節 鞣花單寧酸類化合物 ─ Vescalagin 33 第三章 研究動機與實驗架構 37 第四章 Vescalagin 減緩甲基乙二醛誘發糖類代謝異常之探討 41 第一節 前言 41 第二節 實驗材料 43 一、實驗樣品來源 43 二、實驗動物來源 43 三、實驗動物飼料與墊料 43 四、實驗藥品與試劑 43 五、實驗藥品配製 44 六、儀器設備 44 第三節 實驗方法 46 一、實驗樣品粗萃 46 二、樣品純化製備 46 三、實驗動物之飼養 46 四、實驗動物分組 47 五、空腹血糖 (Fasting serum glucose) 47 六、口服葡萄糖耐受性試驗 (Oral glucose tolerance test )48 七、被動迴避試驗 (Avoidance test) 48 八、動物犧牲 (sacrifice) 48 九、血清葡萄糖濃度分析 49 十、血清胰島素濃度分析 49 十一、血清 C-peptide 分析 49 十二、血清 Fructosamine 濃度分析 49 十三、血清 Methylglyoxal 濃度分析 50 十四、血清Advanced glycation end products (AGEs) 濃度分析 50 十五、血清 D-Lactate 濃度分析 50 十六、血清 Pyruvate 濃度分析 50 十七、血清 TNF-α 濃度分析 50 十八、血清 IL-6 濃度分析 50 十九、血液分析 51 二十、統計分析 51 第四節 結果與討論 52 一、MG餵食八周內大鼠之空腹血糖變化 52 二、MG餵食第八周之口服葡萄糖耐受性試驗 53 三、MG 餵食大鼠之體重及飲食攝水量變化 54 四、MG餵食大鼠其犧牲後之器官組織重量變化 54 五、MG餵食大鼠其犧牲後指標血液生化值 55 六、MG餵食大鼠其犧牲後相關血脂變化 57 七、MG餵食大鼠其犧牲後血液中胰島素及 C-peptide 之含量 59 八、MG餵食大鼠其犧牲後血清中果糖胺及糖化終產物之含量 60 九、MG餵食大鼠其犧牲後血清中甲基乙二醛及其代謝產物含量 61 十、MG餵食大鼠其被動迴避試驗及犧牲後大腦之乙醯膽鹼脂酶活性62 十一、MG餵食大鼠其犧牲後血清中細胞激素含量 63 第五節 結論 65 第五章 Vescalagin保護甲基乙二醛誘發血糖代謝異常之機制探討86 第一節 前言 86 第二節 實驗材料 88 一、實驗動物組織來源 88 二、實驗動物飼料與墊料 88 三、實驗藥品與試劑 88 四、實驗藥品配製 89 五、儀器設備 90 第三節 實驗方法 92 一、實驗動物樣器收集 92 二、組織蛋白質萃取 92 三、西方轉印分析 92 四、統計分析 94 第四節 結果與討論 96 一、VES 改善 MG餵食大鼠其胰臟細胞中糖化終產物受器之蛋白表現 與胰島素釋放之影響 96 二、VES 改善 MG餵食大鼠其胰臟細胞中發炎反應相關蛋白表現之影響 99 三、VES 對 MG餵食大鼠其胰臟細胞中抗氧化酵素活性之影響 100 四、VES減緩 MG餵食大鼠其胰臟細胞發炎反應及Mitogen-activated protein kinases (MAPKs) 途徑之探討 102 第五節 結論 104 第六章 總結 122 第七章 附錄 123 第八章 參考文獻 133 | |
dc.language.iso | zh-TW | |
dc.title | Vescalagin 預防 Methylglyoxal 誘發大鼠醣類代謝異常之研究 | zh_TW |
dc.title | Preventive Effect of Vescalagin on Carbohydrate Metabolic Disorder in Methylglyoxal Treated Rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 鄭瑞棠,吳明昌,徐鳳麟,王進崑,沈賜川 | |
dc.subject.keyword | Vescalagin,甲基乙二醛,過度糖化終產物,發炎反應,胰臟 β 細胞,抗氧化酵素, | zh_TW |
dc.subject.keyword | Vescalagin,methylglyoxal,advanced glycation end products,inflammatory reaction,pantreaticβ cell,antioxidant enzymes, | en |
dc.relation.page | 151 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-01-10 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 5.49 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。